Merck, Moderna Partner on Cancer Vaccine Targeting Tumors

Merck & Co and Moderna Therapeutics are working on a cancer vaccine that targets tumors, according to Reuters. This development comes as scientists explore new ways to combat cancer using immunotherapy.

The project is still in its early stages, but experts say it holds promise for treating various types of cancer, including breast, lung, and colon cancer.

While there's no specific timeline for when this vaccine will be available or how effective it will be, researchers are optimistic about the potential benefits.